BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21476951)

  • 1. Hypocretin antagonists in insomnia treatment and beyond.
    Ruoff C; Cao M; Guilleminault C
    Curr Pharm Des; 2011; 17(15):1476-82. PubMed ID: 21476951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin receptors: pharmacology and therapeutic opportunities.
    Scammell TE; Winrow CJ
    Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin receptor antagonists as therapeutic agents for insomnia.
    Equihua AC; De La Herrán-Arita AK; Drucker-Colin R
    Front Pharmacol; 2013 Dec; 4():163. PubMed ID: 24416019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
    Winrow CJ; Renger JJ
    Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants.
    Yokogawa T; Marin W; Faraco J; Pézeron G; Appelbaum L; Zhang J; Rosa F; Mourrain P; Mignot E
    PLoS Biol; 2007 Oct; 5(10):e277. PubMed ID: 17941721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
    Gerashchenko D; Salin-Pascual R; Shiromani PJ
    Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putting addiction to bed.
    Soares C
    Sci Am; 2010 Jul; 303(1):23-4. PubMed ID: 20583657
    [No Abstract]   [Full Text] [Related]  

  • 12. Orexins and orexin receptors: from molecules to integrative physiology.
    Matsuki T; Sakurai T
    Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the hypocretinergic system in the integration of networks that dictate the states of arousal.
    Winsky-Sommerer R; Boutrel B; De Lecea L
    Drug News Perspect; 2003 Oct; 16(8):504-12. PubMed ID: 14668948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.
    Wu MF; Nienhuis R; Maidment N; Lam HA; Siegel JM
    J Neurosci; 2011 Apr; 31(17):6305-10. PubMed ID: 21525270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin receptor antagonists: medicinal chemistry and therapeutic potential.
    Roecker AJ; Coleman PJ
    Curr Top Med Chem; 2008; 8(11):977-87. PubMed ID: 18673167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological advances in the treatment of insomnia.
    Richey SM; Krystal AD
    Curr Pharm Des; 2011; 17(15):1471-5. PubMed ID: 21476952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin receptor antagonists.
    Christopher JA
    Pharm Pat Anal; 2012 Jul; 1(3):329-46. PubMed ID: 24236845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suvorexant: something new for sleep?
    Reddy A; Puvvada SC; Kommisetti S; El-Mallakh RS; Lippmann S
    Acta Neuropsychiatr; 2015 Feb; 27(1):53-5. PubMed ID: 25397996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.